Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata may be caused by the immune system attacking hair follicles.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

CD8+ T cells play a key role in graft-versus-host disease in certain mice models.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

ILC1-like cells may contribute to hair loss in alopecia areata.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Fetal skin has unique immune cells different from adult skin.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

Belatacept may be a promising treatment for alopecia areata.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Modified superoxide dismutase may trigger an autoimmune response in alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Relatives of lupus patients show signs of immune system activity but not full-blown lupus.

Higher levels of certain immune cells in hair follicles may contribute to alopecia areata.

IL-27 may help prevent hair loss by creating immune-suppressing cells.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.